Midomafetamine: Clinical Trials

3 trials of Midomafetamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Midomafetamine: new trials by email Literature Review of Midomafetamine trials Research Report on Midomafetamine

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Midomafetamine HCl - PTSD
Phase 3CompletedResilient Pharmaceuticals872021-03-082025-06-06
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
Therapy, Midomafetamine, Placebo - Posttraumatic Stress Disorder
Phase 3CompletedResilient Pharmaceuticals1212020-09-022025-06-06
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Therapy, midomafetamine HCl, Placebo - Posttraumatic Stress Disorder
Phase 3CompletedResilient Pharmaceuticals1002018-11-212025-06-06

Conditions studied

Stress Disorders, Post-Traumatic (3)

Sponsors

Resilient Pharmaceuticals (3)

Countries

Israel (3)  ·  United States (3)  ·  Canada (2)

Top investigators

Bessel van der Kolk, MD (1)  ·  Casey Paleos, MD (1)  ·  Cole Marta, MD (1)  ·  Emma Hapke, MD (1)  ·  Josh Woolley, MD, PhD (1)  ·  Michael Bogenschutz, MD (1)  ·  Randall Brown, MD, PhD (1)  ·  Ray Worthy, MD (1)  ·  Revital Amiaz, MD (1)  ·  Scott Shannon, MD (1)  ·  Sylvestre Quevedo, MD (1)  ·  Wael Garas, MD (1)  ·  Yevgeniy Gelfand, MD (1)

Results publications

PMID 33972795, PMID 37709999, PMID 38198456